TY - JOUR
T1 - Mutational signature dynamics shaping the evolution of oesophageal adenocarcinoma
AU - OCCAMS Consortium
AU - Abbas, Sujath
AU - Pich, Oriol
AU - Devonshire, Ginny
AU - Zamani, Shahriar A.
AU - Katz-Summercorn, Annalise
AU - Killcoyne, Sarah
AU - Cheah, Calvin
AU - Nutzinger, Barbara
AU - Grehan, Nicola
AU - Lopez-Bigas, Nuria
AU - Edwards, Paul A.W.
AU - Fidziukiewicz, Elwira
AU - Redmond, Aisling M.
AU - Freeman, Adam
AU - Smyth, Elizabeth C.
AU - O’Donovan, Maria
AU - Miremadi, Ahmad
AU - Malhotra, Shalini
AU - Tripathi, Monika
AU - Coles, Hannah
AU - Flint, Conor
AU - Eldridge, Matthew
AU - Jammula, Sriganesh
AU - Davies, Jim
AU - Crichton, Charles
AU - Carroll, Nick
AU - Hardwick, Richard H.
AU - Safranek, Peter
AU - Hindmarsh, Andrew
AU - Sujendran, Vijayendran
AU - Hayes, Stephen J.
AU - Ang, Yeng
AU - Sharrocks, Andrew
AU - Preston, Shaun R.
AU - Bagwan, Izhar
AU - Save, Vicki
AU - Skipworth, Richard J.E.
AU - Hupp, Ted R.
AU - O’Neill, J. Robert
AU - Tucker, Olga
AU - Beggs, Andrew
AU - Taniere, Philippe
AU - Puig, Sonia
AU - Contino, Gianmarco
AU - Underwood, Timothy J.
AU - Walker, Robert C.
AU - Grace, Ben L.
AU - Lagergren, Jesper
AU - Gossage, James
AU - Chan, David
N1 - Publisher Copyright:
© 2023, The Author(s).
PY - 2023/12
Y1 - 2023/12
N2 - A variety of mutational processes drive cancer development, but their dynamics across the entire disease spectrum from pre-cancerous to advanced neoplasia are poorly understood. We explore the mutagenic processes shaping oesophageal adenocarcinoma tumorigenesis in 997 instances comprising distinct stages of this malignancy, from Barrett Oesophagus to primary tumours and advanced metastatic disease. The mutational landscape is dominated by the C[T > C/G]T substitution enriched signatures SBS17a/b, which are linked with TP53 mutations, increased proliferation, genomic instability and disease progression. The APOBEC mutagenesis signature is a weak but persistent signal amplified in primary tumours. We also identify prevalent alterations in DNA damage repair pathways, with homologous recombination, base and nucleotide excision repair and translesion synthesis mutated in up to 50% of the cohort, and surprisingly uncoupled from transcriptional activity. Among these, the presence of base excision repair deficiencies show remarkably poor prognosis in the cohort. In this work, we provide insights on the mutational aetiology and changes enabling the transition from pre-neoplastic to advanced oesophageal adenocarcinoma.
AB - A variety of mutational processes drive cancer development, but their dynamics across the entire disease spectrum from pre-cancerous to advanced neoplasia are poorly understood. We explore the mutagenic processes shaping oesophageal adenocarcinoma tumorigenesis in 997 instances comprising distinct stages of this malignancy, from Barrett Oesophagus to primary tumours and advanced metastatic disease. The mutational landscape is dominated by the C[T > C/G]T substitution enriched signatures SBS17a/b, which are linked with TP53 mutations, increased proliferation, genomic instability and disease progression. The APOBEC mutagenesis signature is a weak but persistent signal amplified in primary tumours. We also identify prevalent alterations in DNA damage repair pathways, with homologous recombination, base and nucleotide excision repair and translesion synthesis mutated in up to 50% of the cohort, and surprisingly uncoupled from transcriptional activity. Among these, the presence of base excision repair deficiencies show remarkably poor prognosis in the cohort. In this work, we provide insights on the mutational aetiology and changes enabling the transition from pre-neoplastic to advanced oesophageal adenocarcinoma.
UR - http://www.scopus.com/inward/record.url?scp=85164754562&partnerID=8YFLogxK
U2 - 10.1038/s41467-023-39957-6
DO - 10.1038/s41467-023-39957-6
M3 - Article
C2 - 37454136
AN - SCOPUS:85164754562
SN - 2041-1723
VL - 14
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 4239
ER -